The Delhi High Court denied Roche's request to temporarily restrain Natco Pharma from producing its spinal muscular atrophy drug, citing pu...

The Supreme Court has instructed Zydus Lifesciences to approach the Delhi High Court. Zydus is seeking relief from an order that prevents t...

The Delhi High Court division bench has allowed Zydus Lifesciences to sell its breast cancer drug Sigrima amidst accusations of it being si...

Antibodies are markers of infection, and testing for them helps health officials see how widely the virus has spread. Until now, most tests...

Hospitals and reference laboratories can run the Elecsys Anti-SARS-CoV-2 test on one of Roche’s analysis platforms, the company said. Roche...

According to the CIC, Roche Group is dominant in the relevant market and can operate independently of the market forces.

The amount of political risk being created by Trump and his administration is going to create an enormous amount of international tension a...

Roche sued Zydus Cadila and the DCGI last week, alleging that the Indian company launched its product, Vivitra, in the country without gene...

At 10:00 a.m.; the stock was at Rs 617.45, down 1.80 per cent, on the BSE. It touched a high of Rs 630 and a low of Rs 614.10 in early trad...

Swiss voters rejected a proposal to limit executives’ pay to 12 times that of junior employees on Sunday.

Pfizer Ltd, the India unit of US drugmaker Pfizer Inc, will challenge the country's patent office for revoking a patent for its cancer drug...

A takeover of Illumina would be Roche’s largest purchase since the $46.8 billion acquisition of Genentech Inc., completed in March 2009.

Pharmaceuticals maker Roche Holding AG says net income was down 29 per cent for the first half after the takeover of Genentech.

Swiss pharmaceutical giant Roche agreed to pay $46.8 billion to buy the 44% of biotech pioneer Genentech that it doesn’t already own, endin...

Roche Holding AG lowered the acquisition price by 2.8% and took the offer for the US cancer-drug developer directly to shareholders.

Health ministry says not equipped with technical expertise to stop domestic pharmaceutical cos from copying patented drugs.

Pharmaceuticals maker Roche Holding AG said on Tuesday it is poised to complete its acquisition of Ventana Medical Systems Inc.